EW - Edwards Lifesciences Corporation
129.52 -0.08 (-0.06%)
After hours: 4:12PM EDT
| Previous Close | 134.67 |
| Open | 124.01 |
| Bid | 128.80 x 500 |
| Ask | 129.51 x 100 |
| Day's Range | 123.00 - 130.75 |
| 52 Week Range | 100.20 - 143.22 |
| Volume | 5,330,429 |
| Avg. Volume | 1,387,191 |
| Market Cap | 27.267B |
| Beta | 0.68 |
| PE Ratio (TTM) | 47.97 |
| EPS (TTM) | 2.70 |
| Earnings Date | Apr 23, 2018 - Apr 27, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 146.37 |
- CNBC Videos•yesterday
Edward Life Sciences drops on mixed earnings release
CNBC's Kate Rogers reports on the quarterly earnings for Edward Life Sciences.
- CNBC Videos•5 days ago
Cramer's lightning round: Edwards Lifesciences is simplif...
Jim Cramer flies through his take on callers' favorite stocks, including a biotech play.
- Zacks•5 hours ago
Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss
Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q1.
- Investor's Business Daily•8 hours ago
Premarket: Futures Improve As Boeing, Twitter, 3 Chip Stocks Soar
Premarket trading turned mixed on Wednesday as Boeing, Twitter and Cree gained, Alphabet got an upgrade and Comcast bid $31 billion for Britain's Sky.
- Market Realist•9 hours ago
What Drove Edwards Lifesciences’ 1Q18 Earnings?
Japan is the company’s highest growth region outside the United States. Therapy adoption continues to be the major factor driving Edwards’ THVT segment sales in 1Q18. For more on related developments, read Recent Developments at Edwards Lifesciences.
- Market Realist•9 hours ago
Edwards Lifesciences Missed Sales Estimates in 1Q18
Edwards Lifesciences Stock Fell on Missed 1Q18 Sales EstimatesEdwards Lifesciences releases 1Q18 results
- InvestorPlace•9 hours ago
3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)
Edwards Lifesciences Corp (NYSE:EW) and Illumina, Inc. (NASDAQ:ILMN) reported their quarterly earnings results after hours Tuesday, while Tesla Inc (NASDAQ:TSLA) finds itself in hot waters over a contract dispute. Edward Lifesciences reported its latest quarterly results after hours yesterday. The company announced that the first-quarter global sales of its heart valves, a metric that marks the company’s most important growth driver, increased 2.3% year-over-year to $551.5 million.
- Thomson Reuters StreetEvents•12 hours ago
Edited Transcript of EW earnings conference call or presentation 24-Apr-18 9:00pm GMT
Q1 2018 Edwards Lifesciences Corp Earnings Call
- Reuters•22 hours ago
Edward Lifesciences' heart valve sales in Europe disappoint, shares fall
Edwards Lifesciences Corp's first-quarter sales for transcatheter heart valves missed Wall Street targets on Tuesday, as the medical device maker lost market share in Europe to its rival, Medtronic Plc. The company's shares fell as much as 8.1 percent in after-market trading as sales of its premium non-invasive device, used to replace diseased aortic valves without open-heart surgery, is its biggest growth driver. "Procedure growth in Europe was double digits this quarter, while our growth was lower due to a year-over-year shift in share to our largest competitor," Chief Executive Officer Michael A. Mussallem said on a call with analysts.
- MarketWatch•22 hours ago
Edwards Lifesciences stock drops 8% after forecast misses
Edwards Lifesciences Corp. shares dropped in late trading Tuesday after the company provided a disappointing forecast. The company reported first-quarter earnings of 96 cents a share on sales of $894.8 ...
- Investor's Business Daily•22 hours ago
Despite Today's Market, Baozun And Solaredge Technologies Join Sector Leaders
Here’s a list of all the top-rated growth stocks that have just been added to the IBD 50, IBD Big Cap 20, Sector Leaders, Stock Spotlight and IPO leaders.
- Investor's Business Daily•23 hours ago
Edwards Lifesciences Tanks After Heart-Valve Sales Lag Expectations
For the first quarter, Edwards reported $937.5 million in adjusted sales and adjusted profit of $1.22 per share.
- CNBC•23 hours ago
After-hours buzz: TXN, WYNN, EW & more
See which stocks are posting big moves after the bell.
- Zacks•yesterday
The Hottest Earnings Charts This Week
All eyes will be on these hot stocks during this busy earnings week.
- Associated Press•yesterday
Edwards Lifesciences: 1Q Earnings Snapshot
On a per-share basis, the Irvine, California-based company said it had net income of 96 cents. Earnings, adjusted for non-recurring costs, were $1.22 per share. The results beat Wall Street expectations. ...
- Reuters•yesterday
Edwards Lifesciences reports 1.3 pct rise in quarterly sales
Medical device maker Edwards Lifesciences Corp reported a 1.3 percent rise in first-quarter revenue on Tuesday on higher demand for transcatheter heart valves, its biggest business. The company's net profit ...
- PR Newswire•yesterday
Edwards Lifesciences Reports First Quarter Results
IRVINE, Calif. , April 24, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
- ACCESSWIRE•yesterday
Edwards Lifesciences Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 24, 2018 / Edwards Lifesciences Corporation (NYSE: EW ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 24, 2018 at 5:00 PM Eastern ...
- Market Realist•yesterday
Will BSX’s 1Q18 Results Support Its Upward Trend?
Over the last month, BSX stock has registered a rise of ~4.2%. The company came out on top in patent infringement litigation against Edwards Lifesciences (EW), for which a hearing is scheduled in May at the German Court of Appeal. On April 16, Boston Scientific announced its acquisition of Nvision Medical Corporation for a cash payment of $150 million and an additional milestone-based payment over the next four years amounting to $125 million.
- Market Realist•yesterday
Will Boston Scientific Beat 1Q18 Earnings Estimates?
In 1Q18, Boston Scientific (BSX) is expected to report adjusted EPS (earnings per share) of $0.32, representing YoY (year-over-year) growth of ~8.7%. The company reported adjusted EPS of $0.34 in fiscal 4Q17, and it had registered YoY growth of ~14.8%. The adjusted EPS were in line with Wall Street expectations.
- Market Realist•2 days ago
Boston Scientific’s 1Q18 Revenues: What to Expect
On April 25, Boston Scientific (BSX) plans to announce its 1Q18 earnings results—the quarter that ended on March 31. According to Wall Street analysts’ estimates, the company’s 1Q18 revenues are expected to come in at $2.34 billion, representing YoY (year-over-year) growth of ~8.4%.
Market Realist•2 days agoWhat to Expect from Edward Lifesciences’ 1Q18 Earnings
Edwards Lifesciences (EW) will announce its 1Q18 earnings results for the quarter ended March 31, 2018, on April 24. The company is a leader in the TAVR (transcatheter aortic valve replacement) market space and manufactures the market-leading Sapien family of valves. The company reported robust 4Q17 and fiscal 2017 results on February 1, 2018, which triggered a 7% of stock price rise.
Market Realist•2 days agoBoston Scientific: The Word on Wall Street ahead of 1Q18 Earnings
The company has been growing aggressively through strategic acquisitions. This month, the company announced the acquisition of Nvision Medical Corporation in the area of women’s health and Securus Medical in the area of electrophysiology. The company is slated to announce its 1Q18 earnings results on April 25. In this article, let’s discuss the company’s Wall Street recommendations and target prices for the next 12 months.
- Zacks•2 days ago
Why Earnings Season Could Be Great for Edwards Lifesciences (EW)
Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
- CNBC•5 days ago
Cramer's lightning round: Edwards Lifesciences is simplifying heart surgery, and it's a buy
It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Edwards Lifesciences Corp. EW : "Oh, that is a great company and they have the best device. Align Technology ALGN : "The stock is breaking down here.
